Jazz Pharmaceuticals plc — Director's Dealing 2019

Dec 9, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Jazz Pharmaceuticals plc (JAZZ)
CIK: 0001232524
Period of Report: 2019-12-05

Reporting Person: Carr Patricia (VP, Finance & PAO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-12-05	Ordinary Shares	M	1667	$123.36	Acquired	7549	Direct
2019-12-05	Ordinary Shares	S	1667	$148.889	Disposed	5882	Direct
2019-12-05	Ordinary Shares	S	82	$149.84	Disposed	5800	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-12-05	Non-Qualified Stock Option (right to buy)	$123.36	M	1667	Disposed	2026-02-24	Ordinary Shares (1667)	Direct

Footnotes

F1: Includes 82 ordinary shares acquired under a Section 423 Employee Stock Purchase Plan on November 29, 2019.

F2: These options were granted pursuant to the Issuer's 2011 Equity Incentive Plan. The ordinary shares subject to these options vest over four years measured from the grant date, February 25, 2016, with 1/4th vesting on the first anniversary of the grant date and the remainder vesting in 36 equal monthly installments thereafter.